ПРИМЕНЕНИЕ МУКОАКТИВНЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ В ПРАКТИКЕ ТЕРАПЕВТА
Архивъ внутренней медицины, 2013 Russia is among the countries where using of mucolytic drugs in clinical practice is widespread. In chronic bronchitis, chronic obstructive pulmonary disease, acute respiratory syndrome with prolonged cough, pneumonia, tuberculosis and many other ...
Ф. Т. Малыхин +2 more
doaj +1 more source
POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19)
Фармация и фармакология (Пятигорск), 2022 The aim. To identify polypharmacy cases and develop the ways to optimize pharmacotherapy of patients with COVID-19 hospitalized in infectious disease facilities.Materials and methods.
V. I. Petrov +3 more
doaj +1 more source
Analysis of fixed dose combinations of expectorants, antitussives, decongestants, antihistamines and mucolytics available in the Indian market for rationality and cost variation [PDF]
, 2023 Background: Aim of the current study was to analyze the FDCs of expectorants, antitussives, decongestants, antihistamines and mucolytics available in the Indian market for their rationality, cost, and dosage forms.
Rohan A. +2 more
core +1 more source
, 2020 Supplemental material, Fig_S1 for A Prospective Randomized Clinical Trial of Combination Therapy with Proton Pump Inhibitors and Mucolytics in Patients with Laryngopharyngeal Reflux by Minsuk Chae, Dong Hyuk Jang, Ho Chan Kim and Minsu Kwon in Annals of ...
Minsu Kwon (3183951) +3 more
core +1 more source
Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy
Life, 2022 SARS-CoV-2 infection leads to a heterogenous spectrum of clinical conditions ranging from self-limiting upper airway infection to severe respiratory failure.
Andrea Bianco +8 more
doaj +1 more source
Simple Answers to Complex Questions about Mucolytics for Children
Вопросы современной педиатрии, 2015 The article discusses the use of N-acetylcysteine in pediatric practice and examines various clinical effects of acetylcysteine, including in acute respiratory infections in children, and peculiarities of its application. The causes for the phenomenon of
O. I. Simonova
doaj +1 more source
Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease
Biomolecules, 2021 In cystic fibrosis (CF), the accumulation of viscous lung secretions rich in DNA and actin is a major cause of chronic inflammation and recurrent infections leading to airway obstruction.
Danila Delfino +9 more
doaj +1 more source
Possibilities of topical antibacterial drugs in practice of ENT-doctors
Медицинский совет, 2020 Introduction. Antibiotic resistance is a topic that is currently causing concern for all of humanity in the world. Experts at the World Health Organization consider it a global threat. Irrational and uncontrolled use of antibacterial drugs, the low level
K. V. Eremeeva +2 more
doaj +1 more source
Modern approaches to the prescription of mucolytics and expectorants in the daily pediatric practice [PDF]
, 2019 The article presents the clinical evidence of safety and efficacy of mucolytics and expectorants in the treatment of both productive and non-productive coughs in respiratory infections in childhood in all stages of the infectious-inflammatory process ...
O. I. Pikuza +3 more
core +1 more source
Conservative Treatment of Benign Prostatic Hyperplasia: The Use of Mucolytics
, 2008 The authors propose the use of alpha-blockers and 5 alpha-reductase inhibitors for the management of benign prostatic syndrome. As another group of substances for therapeutic use, I would suggest secretolytics and mucolytics.
Kuno Kirschfeld, Kirschfeld, K.
core +1 more source